Axonyx set to develop rapid Alzheimer's test
This article was originally published in Clinica
Executive Summary
US biotechnology company Axonyx is to develop a rapid and specific test for Alzheimer's disease jointly with the Department of Pathology at the University of Melbourne in Australia, where the diagnostic method was discovered.